Correction of F508del-CFTR trafficking by the sponge alkaloid latonduine is modulated by interaction with PARP.

[1]  K. Du,et al.  Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and Function , 2012, Cell.

[2]  P. Negulescu,et al.  Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809 , 2011, Proceedings of the National Academy of Sciences.

[3]  J. Clancy,et al.  Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation , 2011, Thorax.

[4]  David Y. Thomas,et al.  Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. , 2011, Chemistry & biology.

[5]  W. Kraus,et al.  Clickable NAD analogues for labeling substrate proteins of poly(ADP-ribose) polymerases. , 2010, Journal of the American Chemical Society.

[6]  Bart Kus,et al.  Correction of the ΔPhe508 Cystic Fibrosis Transmembrane Conductance Regulator Trafficking Defect by the Bioavailable Compound Glafenine , 2010, Molecular Pharmacology.

[7]  J. Gagné,et al.  Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry , 2010, Proteome Science.

[8]  T. Helleday,et al.  PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA* , 2010, The Journal of Biological Chemistry.

[9]  Michelle S. Scott,et al.  Chemogenomic profiling predicts antifungal synergies , 2009, Molecular systems biology.

[10]  Leatrice N Vogel,et al.  CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium , 2009, PLoS biology.

[11]  D. Sheppard,et al.  Gating of the CFTR Cl− channel by ATP‐driven nucleotide‐binding domain dimerisation , 2009, The Journal of physiology.

[12]  S. Licht,et al.  An activity-based protein profiling probe for the nicotinic acetylcholine receptor. , 2008, Journal of the American Chemical Society.

[13]  Mechthild Krause,et al.  A novel poly(ADP-ribose) polymerase inhibitor, ABT-888, radiosensitizes malignant human cell lines under hypoxia. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Donglei Zhang,et al.  Structural Analog of Sildenafil Identified as a Novel Corrector of the F508del-CFTR Trafficking Defect , 2008, Molecular Pharmacology.

[15]  Jason C. Young,et al.  Multiple 40-kDa heat-shock protein chaperones function in Tom70-dependent mitochondrial import. , 2007, Molecular biology of the cell.

[16]  Donglei Zhang,et al.  Correctors of Protein Trafficking Defects Identified by a Novel High‐Throughput Screening Assay , 2007, Chembiochem : a European journal of chemical biology.

[17]  D. Noonan,et al.  Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors. , 2006, International journal of oncology.

[18]  John D. Venable,et al.  Hsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis , 2006, Cell.

[19]  M. Wilke,et al.  Rescue of functional delF508‐CFTR channels in cystic fibrosis epithelial cells by the α‐glucosidase inhibitor miglustat , 2006, FEBS letters.

[20]  D. Clarke,et al.  Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound. , 2005, Molecular pharmaceutics.

[21]  A. Beaudet,et al.  Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[22]  J. Tramper,et al.  Marine Sponges as Pharmacy , 2005, Marine Biotechnology.

[23]  J. Best,et al.  Salivary secretion assay for drug efficacy for cystic fibrosis in mice , 2005, Experimental physiology.

[24]  C M Harris,et al.  Sildenafil (Viagra) corrects ΔF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis , 2004, Thorax.

[25]  A. Maresso,et al.  Ezrin/Radixin/Moesin Proteins Are High Affinity Targets for ADP-ribosylation by Pseudomonas aeruginosa ExoS* , 2004, Journal of Biological Chemistry.

[26]  C. Szabó,et al.  Poly(ADP-ribose) polymerase activity contributes to peroxynitrite-induced spinal cord neuronal cell death in vitro. , 2004, Journal of neurotrauma.

[27]  K. Du,et al.  Curcumin, a Major Constituent of Turmeric, Corrects Cystic Fibrosis Defects , 2004, Science.

[28]  S. Brody,et al.  Foxj1 is required for apical localization of ezrin in airway epithelial cells , 2003, Journal of Cell Science.

[29]  Roger G. Linington,et al.  Latonduines A and B, new alkaloids isolated from the marine sponge Stylissa carteri: structure elucidation, synthesis, and biogenetic implications. , 2003, Organic letters.

[30]  M. Endres,et al.  Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. , 2001, International journal of molecular medicine.

[31]  P. Zeitlin,et al.  In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. , 1997, The Journal of clinical investigation.

[32]  P. French,et al.  A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo. , 1996, The Journal of clinical investigation.

[33]  J. Wine,et al.  Glycerol Reverses the Misfolding Phenotype of the Most Common Cystic Fibrosis Mutation (*) , 1996, The Journal of Biological Chemistry.

[34]  R. Boucher,et al.  Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. , 1994, Science.

[35]  S Grinstein,et al.  The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. , 1993, The Journal of biological chemistry.

[36]  Pascal Barbry,et al.  Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation , 1991, Nature.

[37]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[38]  L. Tsui,et al.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. , 1989, Science.

[39]  A. Naura,et al.  The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport. , 2012, Cellular signalling.

[40]  John R Yates,et al.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. , 2010, Nature chemical biology.

[41]  M. Welsh,et al.  Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. , 1992, The Journal of clinical investigation.